Everhart Financial Group Inc. Sells 336 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Everhart Financial Group Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,292 shares of the healthcare conglomerate’s stock after selling 336 shares during the period. Everhart Financial Group Inc.’s holdings in UnitedHealth Group were worth $2,171,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in UNH. AMF Tjanstepension AB increased its holdings in shares of UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the last quarter. Hudson Value Partners LLC boosted its stake in shares of UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 82 shares during the period. Wealth Group Ltd. boosted its stake in shares of UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after purchasing an additional 68 shares during the period. Creative Planning boosted its stake in shares of UnitedHealth Group by 11.0% during the 3rd quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock worth $123,025,000 after purchasing an additional 21,114 shares during the period. Finally, Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth about $341,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $523.48 on Friday. The company’s fifty day moving average price is $523.11 and its 200 day moving average price is $563.18. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market capitalization of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on UNH. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.